£68.00

Degenerative dementias: clinical aspects, scintigraphy and cerebrospinal fluid biomarker profile

Medical & Healthcare Practitioners

Price data last checked 14 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£68 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 77 days • 1 price levels

Days at Price

Price Analysis

Most common price: £68 (77 days, 100.0%)

Price range: £68 - £68

Price levels: 1 different prices over 77 days

Description

We recruited 40 patients (16 men and 24 women). The mean age of these patients was 69±11.78 years [36-86 years]. On the basis of clinical data, we suggested Alzheimer's disease (AD) in 26 patients, frontotemporal lobar degeneration in 7, dementia with Lewy bodies (MLD) in 4, and 3 patients were classified in the group of other types of dementia (progressive supra-nuclear palsy, cortico-basal degeneration and multisystematic atrophy). For AD, the sensitivity and specificity of the 3 biomarkers (Aβ (1-42), T-tau and P-tau) were 82% and 100% respectively. Concordance between neuropsychological test results, scintigraphic appearance and biomarker profile was noted in 77.5% of cases. MIBG myocardial scintigraphy was of interest in the diagnosis of In DD, no single examination proved of sufficient value to pinpoint the etiology. Convergent data from certain paraclinical examinations are necessary in early and atypical forms, particularly in cases of persistent diagnostic doubt.

Product Specifications

Format: paperback
ASIN: 6208972477
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners
Domain: Amazon UK
Release Date: 18 June 2025
Listed Since: 21 June 2025

Barcode

No barcode data available

Degenerative dementias: clinical aspects, scintigraphy and cerebrospinal fluid biomarker profile

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

A Clinical Guide to Alzheimer's Disease

Chronic kidney disease overview

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Imaging Dementia: Essentials for Clinical Practice

Neurodegenerative Disease: From Molecular Basis to Therapy

Diagnostic and Therapeutic Advances in Alzheimer's Disease

Depression in childhood: Ontogenesis and clinical dynamics

The Molecular and Clinical Pathology of Neurodegenerative Diseases

A Clinician's Guide to Neurodegenerative Disorders

Models of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Molecular Imaging of Neurodegenerative Disorders

Oral Hygiene and Systemic Disease

Neurological Disorders: Insights into Disease Biology (Neuroscience of Neurodegenerative Disease)

Parkinson's Disease: From Clinical Aspects to Molecular Basis

Unravelling Alzheimer’s: Innovations in Pathogenesis, Diagnosis, and Therapeutics

Unravelling Alzheimer’s: Innovations in Pathogenesis, Diagnosis, and Therapeutics

Clinical Neurology: Role of Biomarkers

Determinants of delinquency and bank credit risk management

Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach

Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias

Nanotherapeutics for Treating Neurodegenerative Disorders

Living with Dementia: Neuroethical Issues and International Perspectives (Advances in Neuroethics)

Optical Coherence Tomography in Multiple Sclerosis: Clinical Applications

Hydrocephalus: From Diagnosis to Treatment (Neurology - Laboratory and Clinical Research Developments)